10 Jun Axes Health is pleased to announce it has acquired Reproclinic and Ovoclinic Barcelona with the strategy to merge both entities into a top-tier facility downtown Barcelona under the name of Reproclinic Barcelona.
Reproclinic creates individualised fertility treatment programs that are tailored to patient’s needs through excellent customer care, integrative patient support and stress-free fertility journey. Patient experience is a fundamental concept at Reproclinic. Thanks to its adaptability to different markets and patients, Reproclinic treated patients from more than 20 different countries. Specialized in gamete donation programs, every detail of the experience contributes to success, making all the entire fertility treatment process manageable, safe, easy and relaxing. “Having the opportunity to merge with Ovoclinic Barcelona into the most advanced fertility premises and benefit from the ongoing strategic support from Axes Health international clinics will allow us to soon establish Reproclinic as the primary destination in Spain attracting both patients as well as talented staff, our secret recipe to a successful experience” says Esther Velilla, CEO of Reproclinic.
Axes Health is an international strategic holding focused on developing and managing top-tier healthcare facilities in the fields of Fertility and Women’s Health. Axes sets itself apart by providing best in class patient care fostered by its multidisciplinary and holistic approach, expert operating teams, and established knowledge transfer practices across group clinics to ensure cutting edge science and industry leading patient care. With a team of more than 100 professionals, Axes Health’s major strategic focus is to build, acquire and manage premium fertility centers in geographies focused on medical tourism, within stable legislative regimes benefitting from a stable talent pool allowing the centers to offer unparalleled patient experience and results. Starting with the acquisition of the first Czech IVF private group UNICA in 2014, with clinics in the cities of Prague and Brno, Axes now enters the established Spanish IVF market through its investment in Reproclinic Barcelona. “We can’t wait for the next chapter of our partnership with the experienced teams of Reproclinic and Ovoclinic Barcelona. Our continued exchanges will allow us to sustain a unrivaled fertility treatment approach for our patients, and further enhance the group’s gold standard in both patient care and patient experience to be applied not only at our Group level, but also amongst the many scientific and research focused initiatives we are proud to be part of. This is the only way to truly make a difference in our everyday mission of helping our patients to fulfill their dream of having a baby.” says Edouard Perra, CEO of Axes Health.